|
|
<p>The Department has not undertaken an assessment of which countries provide human papillomavirus (HPV) vaccination for boys, which have published plans to implement such programmes, or the impact of such programmes where they have been implemented.</p><p>The report, <em>Milestones in HPV Prevention: Achievements and future potential of the cervical screening and HPV immunisation programmes,</em> published in January 2018 by the vaccine manufacturer MSD states that, by March 2017, HPV vaccination had been introduced for boys in 11 countries. It also summarises recommendations for gender-neutral vaccination in a number of European countries. A copy is attached.</p><p>From information in this report and local intelligence from Public Health England (PHE), the following 11 countries are thought to have introduced HPV vaccination for boys (or are planning to do so): Argentina, Australia, Austria, Canada (in some provinces), Croatia, Israel, Italy (in some provinces), Liechtenstein, Serbia, Switzerland and the United States of America. It is also understood that HPV vaccination for boys is recommended in Ireland, Norway and Sweden but has not yet been introduced.</p><p>It is still relatively early to detect substantial declines in HPV in males and it may not be possible to fully separate the impact from direct protection in boys, from that produced by the indirect effect of vaccinating girls (through herd immunity).</p><p>PHE and the Joint Committee on Vaccination and Immunisation will continue to review results from studies conducted to monitor the impact of vaccination in countries who offer national HPV vaccination for females and males.</p> |